Andrew Hendifar, MD
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma (NCT05336266) | Andrew Hendifar, MD | 2022-07-01 |
| Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma (NCT04798781) | Andrew Hendifar, MD | 2021-07-28 |
| Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency (NCT04098237) | Andrew Hendifar, MD | 2020-12-17 |
| Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain (NCT04034745) | Andrew Hendifar, MD | 2020-10-01 |
| Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia (NCT03207724) | Andrew Hendifar, MD | 2017-10-16 |
Track Andrew Hendifar, MD automatically
Every clearance here is in the API, with alerts when new ones post.